Literature DB >> 3502665

Isolation of EGF-dependent transforming growth factor (TGF beta-like) activity from culture medium conditioned by fetal rat calvariae.

M Centrella1, E Canalis.   

Abstract

A transforming growth factor of the beta class (TGF-beta), defined by its ability to induce normal rat kidney cells (NRK, clone 49F) to form anchorage-independent large colonies in soft agar in the obligate presence of epidermal growth factor, has been prepared from culture medium conditioned by fetal rat calvariae. This activity was purified by acetic acid extraction, gel permeation chromatography, and two reversed-phase HPLC (rpHPLC) steps. Bone culture derived-TGF beta-like activity was soluble in 1.0 M acetic acid, eluted from Sephadex G-75 at relative molecular mass (Mr) 25,000, from mu Bondapak C18 rpHPLC at 63 +/- 5% methanol in 0.1 M acetic acid, and from mu Bondapak CN rpHPLC at 36 +/- 2% n-propanol in 0.1% trifluoroacetic acid. Based on specific activity estimations at each stage of purification, TGF beta-like activity was purified 2500-fold with a 14% recovery, and 1 l of conditioned medium yielded 1-2 micrograms of factor. Silver-stained polyacrylamide gels of this material after CN mu Bondapak rpHPLC revealed a predominant band of (Mr) 24,000.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502665     DOI: 10.1002/jbmr.5650020106

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

1.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Src is a major signaling component for CTGF induction by TGF-beta1 in osteoblasts.

Authors:  X Zhang; J A Arnott; S Rehman; W G Delong; A Sanjay; F F Safadi; S N Popoff
Journal:  J Cell Physiol       Date:  2010-09       Impact factor: 6.384

3.  Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats.

Authors:  T Takano-Yamamoto; G A Rodan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Vitamin D deficiency causes a selective reduction in deposition of transforming growth factor beta in rat bone: possible mechanism for impaired osteoinduction.

Authors:  R D Finkelman; T A Linkhart; S Mohan; K H Lau; D J Baylink; N H Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  Sclerostin-erbB-3 interactions: modulation of erbB-3 activity by sclerostin.

Authors:  Theodore A Craig; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2010-10-14       Impact factor: 3.575

6.  Demonstration of reduced mitogenic and osteoinductive activities in demineralized allogeneic bone matrix from vitamin D-deficient rats.

Authors:  R T Turner; J Farley; J J Vandersteenhoven; S Epstein; N H Bell; D J Baylink
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

7.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.

Authors:  R D Finkelman; N H Bell; D D Strong; L M Demers; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Adenylate cyclase-stimulating, bone-resorbing and B TGF-like activities in canine apocrine cell adenocarcinoma of the anal sac.

Authors:  E C Weir; M Centrella; R E Matus; M L Brooks; T Wu; K L Insogna
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

9.  Isolation of growth factors from adult bovine bone.

Authors:  E Canalis; T McCarthy; M Centrella
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

10.  Ets-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts.

Authors:  Max T Geisinger; Randy Astaiza; Tiffany Butler; Steven N Popoff; Sonia Lobo Planey; John A Arnott
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.